{"disease":{"id":"crohn-s-disease-cd","name":"crohn s disease cd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04806620","title":"Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Brain Inflammation Collaborative","has_results":false},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT04089514","title":"A Real-world Study of Imraldi® Use","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT07237516","title":"Zymfentra (Infliximab-dyyb) REal World Cohort STudy","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT07010926","title":"A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"L2 Bio, LLC","has_results":false},{"nct_id":"NCT07123350","title":"Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT04779320","title":"A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT03801928","title":"Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease","phase":"","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT02782663","title":"A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT07528040","title":"An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":88,"lead_sponsor_name":"Shanghai 10th People's Hospital","has_results":false},{"nct_id":"NCT02778464","title":"Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease","phase":"","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"The Royal Wolverhampton Hospitals NHS Trust","has_results":false},{"nct_id":"NCT06895772","title":"Microbial Community Characteristics in Intestinal Mucosal Tissue of Patients With CD","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Shandong University","has_results":false},{"nct_id":"NCT07309744","title":"Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT06922331","title":"Upadacitinib for Refractory IBD in Asian Children and Elderly: Age-Stratified Analysis","phase":"","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT07113431","title":"Partial-enteral Nutrition Protocol for Crohn's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Kate Farms Inc","has_results":false},{"nct_id":"NCT04271748","title":"The Impact of Time Restricted Feeding in Crohn's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}